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The Jervis Street Drug Advisory and Treatment Centre, Dublin, has recorded a 75% increase 
in attendance of drug addicted patients in 1980, 25% of these being women in the 
childbearing age.1 As a reflection of this increase in the incidence of drug abuse in Dublin, we 
delivered nine heroin addicted mothers in 1981, whereas only six such mothers delivered in 
the previous eight years (Figure 1). Seventeen babies were born as two mothers were confined 
twice. 
 This report describes the profile of the drug addicted mother and the effect on the fetus 
and newborn infant. The high failure rate of the current methods of management emphasises 
the need for an increased awareness of the problem and the early involvement of the 
expectant mother in an active and organised programme. 
Pattern of Drug Abuse 
Thirteen of the fifteen mothers attended the Drug Advisory and Treatment Centre. Although 
they were heavily drug dependent by the time of first contact, the length of drug abuse was on 
average only two years. Twelve of the fifteen were taking opiates, usually heroin: other 
common drugs of abuse were barbiturates, cocaine, amphetamines and hallucinogens. 
Maternal Data and Family 
Background (Table 1) 
Maternal age ranged from 16 years to 30 years; the majority of mothers (69%) being less than 
20 years. Ten of the 
Table 1 
Background data on 13 drug addicted mothers 
 Number Percentage 
Unmarried at time of conception 10 76.9% 
Social Class I and 11 4 30.7% 
                  VI and VII 9 69.2% 
Living at home 3 23.0% 
Secondary education 4 30.8% 
Psychiatric history 9 69.2% 
Serum hepatitis 7 53.8% 
Venereal disease 2 15.4% 
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Table 2 
Perinatal care and problems among 15 drug addicted mothers 
 Number of Mothers Percentage 
Antenatal care 13 86.6% 
Attended Jervis Street 13 86.6% 
Motivation: Good  3 20.0% 
                    Poor 2 13.3% 
                    None 10 66.6% 
Pre-eclampsia 1 6.6% 
Fetal distress 3 20.0% 
Emergency section 2 13.3% 
fifteen were single at the time of conception. They came from families of widely varying 
social classes and a third of the parents had a nervous or psychiatric background. In only three 
of thirteen cases was the relationship between the girls and their parents described as good 
and only three were living at home at the time of contact. Educational attainment was low. 
Four attended secondary school and only one of these remained to pass the Leaving 
Certificate. Almost all had a history of truancy. As a result half were unemployed at the time 
of first contact. 
 As regards living conditions, the sample could be separated into a younger group w ho 
lived at home during their pregnancy and an older group who led a nomadic existence. Five of 
these were squatting in houses due for demolition. In all cases except two were the conditions 
for bringing up children said to be totally inadequate. 
 There was a high incidence of emotional and physical illness among the group, nine 
having received treatment for emotional or psychiatric disorders in the past. Seven of the 
mothers had hepatitis although only one was HBs Ag positive while pregnant. Two mothers 
had venereal disease. One had a positive VDRL slide test in her first pregnancy. The second 
was diagnosed as having gonorrhoea only when her infant developed gonococcal ophthalmia. 
 All but one of the fathers were drug addicts. Half of them were in trouble with the law, 
a quarter drank to excess and one-third were reported as being very violent. Only two gave 
the mother any support or assistance during pregnancy. 
Perinatal Care (Table 2) 
Two out of fifteen mothers had no antenatal care whatsoever. Overall, half had a good record 
of attendance. However, these were mainly of the previous decade and only three of the 1981 
group were good attenders. Only three showed much determination to remain drug free while 
pregnant. Eight showed no motivation at all and two were ambivalent. 
 Only one patient had pre-eclampsia recorded and this was mild. Fetal distress, defined as 
meconium staining of the liquor or prolonged fetal bradycardia below 100/min, was recorded 
on three deliveries. Two of these had an emergency Caesarean section and both infants were 
born with normal Apgar scores. The remainder were spontaneous vaginal deliveries. 
Newborn Data 
There were seventeen infants in all. The average birth weight was 2.92 Kgs. None of our 
infants was under the 10th centile 
Table 3 
Significant postnatal problems in 17 infants born to drug dependent mothers 
 Number of Infants Percentage 
Jaundice (SBR >170 mmol/1) 6 35.0% 
Jaundice requiring phototherapy 4 23.5% 
Hypocalcaemia (Ca+ + <1.75 mmol/1)   
1973 - 1980 1 12.0% 
1981 4 44.0% 
Sepsis 2 11.7% 
Congenital abnormality 1 5.9% 
Withdrawal symptoms: Mild 3 20.0% 
Moderate 3 20.0% 
Severe 0 0% 
on the Lubchenco growth chart.2 Only two were less than 2,500 gms and both were 
appropriate for gestational age. The average gestational age was 37.8 weeks ranging from 35 
to 40 weeks. There were eight male and nine female infants. All had normal Apgar scores 
although three had shown signs of intra-uterine asphyxia. 
Neonatal Problems (Table 3) 
Six of the seventeen babies had serum bilirubin of 170 mmol/1 or greater and four of these 
received phototherapy. None had hypoglycaemia. Five had hypocalcaemia (serum calcium 
less than 1.75 mmol/1). Four of these belonged to the 1981 group. This may reflect increased 
awareness of the high incidence of hypocalcaemia reported in these babies.3 
 Two babies developed sepsis. One had a congenital pneumonia requiring ventilation for 
six days – group B-B haemolytic streptococcus was isolated from the mother. This baby also 
had a partial plasma exchange transfusion for polycythaemia. The other baby had gonococcal 
ophthalmia. There were no cases of respiratory distress syndrome. Only one congenital 
abnormality was noted: a spina bifida occulta with a small overlaying skin defect. Withdrawal 
symptoms were recorded in six infants, three of the infants being moderately affected. There 
were no cases of severe withdrawal symptoms. 
Outcome 
All the infants survived and, apart from one baby who was adopted, all were discharged home 
to their mothers. Three, however, may now be going into care. These are cases where the 
mother is not considered fit to look after her child because of continuing drug abuse and 
associated psychiatric disorders. 
As regards the mothers, only two are known to have coped well with their babies, attended a 
therapeutic community and are now drug free. Two others developed serious neurotic 
illnesses after withdrawal and another is in long-term hospitalisation with a drug-related 
psychiatric illness. The remainder are still addicted. 
Discussion 
Although the first reviews of neonatal drug addiction began to appear in the literature in 
1956,4 there have been no published reports on the condition in Ireland. This is probably 
because up to now there had been no serious problem. However, our experience during the 
year 1981 points to a marked rise in the number of pregnant addicts. We are now seeing 
approximately one case a month whereas previously more than one case a year was unusual. 
 The pregnant addict can be described only in general terms because population 
characteristics will vary from one hospital to another. In our experience they are usually under 
20 years. Two out of three are single and in their first pregnancy. They come from a wide 
range of social backgrounds and many are from broken homes. All of our patients were 
smokers – usually heavy smokers – and a wide range of drugs was abused, heroin being the 
most popular. 
 The drug addict is greatly at risk for serum hepatitis. Half of our patients were infected 
in the past. Venereal disease, pulmonary infections, cardiac disease (e.g. bacterial 
endocarditis) and skin abscesses are also common.5 
 Most reports stress the high incidence of “small for gestational age” babies in mothers 
who are drug addicted. In one study,3 the incidence of retarded intra-uterine growth among 
drug addicts was five times that for the whole newborn population at that hospital. The 
average duration of drug addiction in that series was 7.1 years. None of our infants was small 
for gestational age despite the fact that the aetiological factors usually associated with 
retarded intrauterine growth, i.e. heavy cigarette smoking, unmarried mothers and poor 
antenatal care were prominent in our patients. However, the average duration of drug 
addiction prior to pregnancy in our series was only two years and we may well see the 
emergence of fetal mal-nourishment and its sequelae as the problem of drug addiction 
becomes more entrenched. The fact that no cases of hypoglycaemia in the newborn occurred 
may also be due to the absence of retarded intrauterine growth in our infants. 
 Low serum calcium levels, said to be frequent in babies having withdrawal symptoms3 
were documented in nearly half of babies born in 1981. Respiratory alkalosis was not looked 
for in the babies. This is said to be present in nearly all infants of drug addicted mothers.6 It 
would be important to document this in future cases to assess the contribution hypocalcaemia 
and alkalosis together play in the symptoms of withdrawal. It has been noted that infants born 
to drug addicted mothers are rarely jaundiced.7 That heroin can stimulate liver enzymes has 
been shown by animal experiments8 and indirect evidence has been obtained from human 
experiments.9 Zelson, however, has reported an increased incidence of jaundice in infants 
born to mothers using methadone.10 This may explain why nearly a quarter of our babies 
received phototherapy. A decreased incidence of respiratory distress has been reported in 
babies of drug addicts.11 Heroin does indeed seem to have an accelerating effect on lung 
maturation.12 However, the absence of hyaline membrane disease in our study can simply be 
explained by the fact that most of our babies were greater than 37 weeks gestation. 
 There were three cases of intrauterine asphyxia in our group, two requiring emergency 
Caesarean sections. This complication, along with aspiration pneumonia,13 has been well 
documented in previous studies. The incidence of prematurity in our study was low compared 
to other series in which a high incidence has been reported.3 
 The management of this problem begins by involving the addicted mother in a 
methadone maintenance programme at an early stage in her pregnancy. These programmes, 
where methadone linctus is administered to the mother on a daily basis, have decreased the 
morbidity associated with addiction by reducing parenteral drug use. Entry into a programme 
also encourages better antenatal care and a more stable drug environment for the mother and 
child.14 Methadone, a long acting narcotic agonist, is very well absorbed orally and need only 
be administered once daily because of its lone half life. It freely diffuses across the placenta, 
but because it is highly protein bound in the maternal serum, the cord blood levels average 
only half those found in maternal blood. It is secreted in the urine and bile and also in breast 
milk but no adverse effects have been reported in the infant as a result of breast feeding from 
a mother on methadone. 
 The current practice in the Jervis Street Drug Advisory Centre is to start the pregnant 
woman on low dose methadone linctus, approximately 25 mgs daily, throughout the course of 
her pregnancy. This may be increased if symptoms of narcotic withdrawal occur, but the daily 
dose should be kept as low as possible as the severity of neonatal withdrawal is related to the 
amount of methadone ingested by the mother.15 
 Signs and symptoms of withdrawal usually occur within 24 to 48 hours of birth. They 
consist of any or all of the following: irritability, jitteriness, tremors, sneezing, vomiting, 
diarrhoea, abnormal suck pattern, abnormal sleep pattern, fever and seizures. Fist sucking is a 
prominent sign of the withdrawing infant and seems to be a form of self sedation. Despite 
this, these infants have a reduced sucking rate and pressure. Finnegan suggested that the most 
significant sign of withdrawal in the neonate is sleep for one hour or less after feeding.16 It is 
known that withdrawal from methadone is more severe than from heroin.17 There is a longer 
recovery phase, there is an increased incidence of seizures and indeed some children will 
enter a second phase of withdrawal, referred to as the “late withdrawal syndrome”, which 
occurs at approximately two to four weeks of age. One notable point in this syndrome is that 
infants may take up to 1½: litres of formula per day at two to three weeks of age. 
 A quiet darkened environment may calm the infant, who should be swaddled but 
protected against skin abrasion. Dehydration may become very severe in infants who develop 
diarrhoea and vomiting. Drug treatment for withdrawal should be started in an infant who 
cannot be calmed and who cannot sleep when wrapping alone is used, in an infant who has 
loose stools or is vomiting. in an infant who has temperature elevation or in an infant who has 
seizures.18 Four drugs are currently used in the treatment of withdrawal in the new born: 
Paregoric (Camphorated tincture of opium). The longest experience has been with paregoric 
which, unlike phenobarbitone and other sedatives, seems to restore normal behaviour without 
imposing depression or interfering with sucking performance. Treatment is usually begun 
with 0.2 ml every three hours. If symptoms are not controlled. the dose is raised by 0.05 ml 
every three hours until symptoms are abated; it is rarely necessary to exceed 0.7 ml per dose. 
The tapering process is begun once symptoms are controlled and proceeds as long as 
withdrawal symptoms do not appear. This may take up to 45 days. Mild tremulousness should 
not prevent further lowering of the dose. Paregoric can only be given orally which is a 
drawback in the vomiting neonate. In that situation morphine sulphate 0.06 to 0.1 mg/kg can 
be given as an emergency initial dose. 
Diazepam (1-2 ma intramuscularly eight hourly) has been used successfully.19 Once 
symptoms are controlled the dose is halved and the length between injections lengthened. 
Treatment with diazepam is usually relatively short lasting from 1.25 to 6 days, when the 
mother is on heroin alone. 
Chlorpromazine is also effective. The usual treatment begins with 2.2 to 3 mg/kg/day orally 
or intramuscularly divided into four doses, which is reduced every two to four days as 
indicated by control of signs and symptoms. 
Phenobarbitone gives good control of central nervous system signs in neonatal withdrawal. 
However, diarrhoea may persist and high doses may sedate the infant and depress the sucking 
reflex. A dose of 5 to 10 mg/kg/day in three or four divided doses is usually sufficient. 
 Our experience in the management of withdrawal symptoms is limited as they occurred 
in only 20% of infants. The reported incidence varies from 40% to 91%.20 Most of our cases 
simply required swaddling and only two required drug treatment. Both were treated with 
phenobarbitone and one also required a single dose of Omnopon. 
 We found that the main problems of our patients were social. Understandable anxiety, 
among the medical and social staff, concerning the social conditions led to longer 
hospitalization and separation of these infants. Apart from one baby who was adopted, all 
eventually returned to their mothers, although three are likely to go into care. Some had 
frequent visits to the outpatients department with management or feeding problems. In 
retrospect, these may have been unrecognised symptoms of the late withdrawal syndrome. 
Others failed to keep their follow-up appointments. A similar situation existed in the United 
States up to the early 1970s, in that there was almost no follow-up of infants born to heroin 
addicted mothers, until the introduction of methadone programmes.18 Since that time surveys 
have shown a high incidence of behaviour disturbances manifested by sleep disturbances, 
hyper-activity and temper tantrums in infants of drug addicted mothers. An abnormally high 
death rate among infants and children in the houses of addicted parents has also been 
reported, with speculation that death is due to abuse or neglect.21 
 Rothstein and Gould18 have developed a system of assessing the risk to the infants of 
sending the child home with the mother. High risk factors include a mother less than 18 years 
or greater than 30 years of age, and a home situation where other members of the family also 
abuse drugs. Active voluntary participation in a drug programme, a short history of drug 
abuse and a mother who has raised other children without problems offer a lower risk to the 
infant. 
 To protect the interests of the child it is essential firstly to recognize the escalation of 
the problem of drug abuse among pregnant women, and secondly to adopt a comprehensive 
approach to their management. Such an approach would include active intervention to ensure 
proper antenatal care and nutrition, a lowering of multiple drug abuse prior to delivery and the 
provision of close follow-up care for the mother and child. 
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